The global clinical trial supplies market was valued at approximately USD 2.58 billion in 2023 and is forecasted to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. This growth is attributed to the increasing globalization of clinical trials and a rise in the number of biologics and biosimilar drugs being tested. The biopharmaceutical industry is also experiencing greater...

The global biosimulation market is experiencing rapid growth, poised to reach a valuation of USD 8.65 billion by 2030, expanding at a robust CAGR of 15.8% during the forecast period. This surge is attributed to the growing need for cost-effective drug development, rising acceptance of biosimulation in regulatory approvals, and increasing focus on personalized medicine. Biosimulation,...

Market Overview Global Lancets Market size and share is currently valued at USD 5.89 billion in 2024 and is anticipated to generate an estimated revenue of USD 12.23 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034...